<DOC>
	<DOCNO>NCT01316679</DOCNO>
	<brief_summary>Specific urine protease group enzymes reliable biomarkers effective gauge response therapy patient hepatocellular carcinoma .</brief_summary>
	<brief_title>An Analysis Urinary Proteases Biomarkers Hepatocellular Carcinoma-101423</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Ability willingness provide write informed consent Must 1890 year age time consent Ability provide urine specimen protocoldefined timepoints Must treatment intervention plan directly relate liver disease ( exclude assign group 3Controls ) Suspected inability , e.g . unwillingness comply study procedure unwillingness provide write consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>HCC</keyword>
	<keyword>Liver Disease without HCC</keyword>
</DOC>